| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-07 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.001 |